134 related articles for article (PubMed ID: 21449319)
1. Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release.
Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
J Nanosci Nanotechnol; 2011 Mar; 11(3):1841-51. PubMed ID: 21449319
[TBL] [Abstract][Full Text] [Related]
2. Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate.
Gaber NN; Darwis Y; Peh KK; Tan YT
J Nanosci Nanotechnol; 2006; 6(9-10):3095-101. PubMed ID: 17048523
[TBL] [Abstract][Full Text] [Related]
3. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
4. Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary delivery.
Charpentier PA; Jia M; Lucky RA
AAPS PharmSciTech; 2008; 9(1):39-46. PubMed ID: 18446459
[TBL] [Abstract][Full Text] [Related]
5. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations.
Sahib MN; Abdulameer SA; Darwis Y; Peh KK; Tan YT
Drug Des Devel Ther; 2012; 6():29-42. PubMed ID: 22393583
[TBL] [Abstract][Full Text] [Related]
7. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes.
Darwis Y; Kellaway IW
Int J Pharm; 2001 Mar; 215(1-2):113-21. PubMed ID: 11250097
[TBL] [Abstract][Full Text] [Related]
8. Engineering drug ultrafine particles of beclomethasone dipropionate for dry powder inhalation.
Xu LM; Zhang QX; Zhou Y; Zhao H; Wang JX; Chen JF
Int J Pharm; 2012 Oct; 436(1-2):1-9. PubMed ID: 22732674
[TBL] [Abstract][Full Text] [Related]
9. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
[TBL] [Abstract][Full Text] [Related]
10. Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases.
De Leo V; Ruscigno S; Trapani A; Di Gioia S; Milano F; Mandracchia D; Comparelli R; Castellani S; Agostiano A; Trapani G; Catucci L; Conese M
Int J Pharm; 2018 Jul; 545(1-2):378-388. PubMed ID: 29678545
[TBL] [Abstract][Full Text] [Related]
11. Limitations of high dose carrier based formulations.
Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
[TBL] [Abstract][Full Text] [Related]
12. Beclomethasone Dipropionate-Loaded Polymeric Nanocapsules: Development, In Vitro Cytotoxicity, and In Vivo Evaluation of Acute Lung Injury.
Chassot JM; Ribas D; Silveira EF; Grünspan LD; Pires CC; Farago PV; Braganhol E; Tasso L; Cruz L
J Nanosci Nanotechnol; 2015 Jan; 15(1):855-64. PubMed ID: 26328450
[TBL] [Abstract][Full Text] [Related]
13. Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels.
Valo H; Arola S; Laaksonen P; Torkkeli M; Peltonen L; Linder MB; Serimaa R; Kuga S; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2013 Sep; 50(1):69-77. PubMed ID: 23500041
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma.
Harrison LI; Kurup S; Wagner C; Ekholm BP; Larson JS; Kaiser HB
Eur J Clin Pharmacol; 2002 Jun; 58(3):197-201. PubMed ID: 12107606
[TBL] [Abstract][Full Text] [Related]
16. An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization.
Ostrander KD; Bosch HW; Bondanza DM
Eur J Pharm Biopharm; 1999 Nov; 48(3):207-15. PubMed ID: 10612031
[TBL] [Abstract][Full Text] [Related]
17. Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler.
Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
AAPS PharmSciTech; 2019 Jan; 20(3):94. PubMed ID: 30690674
[TBL] [Abstract][Full Text] [Related]
18. Improvements in delivery with an extra fine beclomethasone aerosol.
Davies R
Int J Clin Pract Suppl; 1998 Sep; 96():28-32. PubMed ID: 10344031
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]